Zhan Hongjie相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Neoadjuvant serplulimab and SOX chemotherapy for locally advanced gastric cancer: pathological responses and systemic immune signatures from a phase II trial

新辅助serplulimab联合SOX化疗治疗局部晚期胃癌：一项II期试验的病理反应和全身免疫特征

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1702737

Zhan, Hongjie; Liu, Liang; Cai, Mingzhi; Sun, Weilin

免疫/内分泌

发表日期：2025

文献求助收藏

SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analyses.

SUMO化相关基因定义了胃腺癌的预后亚型：整合单细胞分析和机器学习分析

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1527233

Luo Kaiping, Xing Donghui, He Xiang, Zhai Yixin, Jiang Yanan, Zhan Hongjie, Zhao Zhigang

细胞生物学

发表日期：2025

文献求助收藏

Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer

IV期胃癌转化治疗：信迪利单抗联合化疗和阿帕替尼

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.35511

Liu, Yong; Xue, Qiang; Wang, Baogui; Ding, Xuewei; Zhang, Rupeng; Wang, Xiaona; Ke, Bin; Wang, Xuejun; Liu, Ning; Deng, Jingyu; Zhan, Hongjie; Li, Bin; Wu, Liangliang; Cai, Mingzhi; Zhang, Li; Huang, Wenbai; Jin, Peng; Liang, Han

发表日期：2025

文献求助收藏

Clinicopathological characteristics of progressive gastrointestinal stromal tumors and heterogeneity analyses of secondary mutations

进行性胃肠道间质瘤的临床病理特征及继发性突变的异质性分析

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyaf110

Li, Jiaxin; Sun, Lin; Liu, Shasha; Liu, Huimin; Li, Bin; Zhan, Hongjie; Sun, Yan

发表日期：2025

文献求助收藏

Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer

尿苷胞苷激酶2作为胃癌中一种新型的潜在预后和治疗生物标志物

期刊:Translational Cancer Research

影响因子:1.7

doi:10.21037/tcr-2025-1165

Sun, Weilin; Guo, Hui; Cai, Mingzhi; Ma, Gang; Zhang, Li; Yu, Yang; Zhan, Hongjie

发表日期：2025

文献求助收藏

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction

更正：弥漫性大B细胞淋巴瘤中微管相关生物标志物的鉴定及预后预测

期刊:Frontiers in Genetics

影响因子:2.8

doi:10.3389/fgene.2023.1180076

Wu, Wenqi; Liu, Su; Tian, Linyan; Li, Cheng; Jiang, Yanan; Wang, Jinhuan; Lv, Yangyang; Guo, Jing; Xing, Donghui; Zhai, Yixin; Sun, Huimeng; Li, Yuhang; Zhang, Luying; He, Xiang; Luo, Kaiping; Zhan, Hongjie; Zhao, Zhigang

细胞生物学

免疫/内分泌

发表日期：2023

文献求助收藏

EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4

EZH2 通过 E2F1、GLI1、CDK3 和 Mcm4 调控胰腺癌细胞。

期刊:Hereditas

影响因子:2.5

doi:10.1186/s41065-023-00280-1

Li, Hongfeng; Wang, Hailong; Cui, Yunlong; Jiang, Wenhua; Zhan, Hongjie; Feng, Lixia; Gao, Mingyou; Zhao, Kuo; Zhang, Limeng; Xie, Xiaojing; Zhao, Ning; Li, Ying; Liu, Pengfei

细胞生物学

发表日期：2023

文献求助收藏

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction

弥漫性大B细胞淋巴瘤中微管相关生物标志物的鉴定及预后预测

期刊:Frontiers in Genetics

影响因子:2.8

doi:10.3389/fgene.2022.1092678

Wu, Wenqi; Liu, Su; Tian, Linyan; Li, Cheng; Jiang, Yanan; Wang, Jinhuan; Lv, Yangyang; Guo, Jing; Xing, Donghui; Zhai, Yixin; Sun, Huimeng; Li, Yuhang; Zhang, Luying; He, Xiang; Luo, Kaiping; Zhan, Hongjie; Zhao, Zhigang

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics

通过基因突变和临床特征鉴定肝癌潜在生物标志物

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.733478

Cui, Yunlong; Li, Hua; Zhan, Hongjie; Han, Tao; Dong, Yixuan; Tian, Caijuan; Guo, Yixian; Yan, Fang; Dai, Dong; Liu, Pengfei

发表日期：2021

文献求助收藏

Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study

采用氟尿嘧啶植入物进行腹腔化疗联合根治性切除和术后辅助化疗治疗III期胃癌：一项多中心、随机、开放标签、对照临床研究

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.670651

Xu, Yan; Zhang, Rupeng; Li, Chunfeng; Sun, Zhe; Deng, Jingyu; Wang, Xiaona; Ding, Xuewei; Wang, Baogui; Xue, Qiang; Ke, Bin; Zhan, Hongjie; Liu, Ning; Liu, Yong; Wang, Xuejun; Liang, Han; Xue, Yingwei; Xu, Huimian

发表日期：2021

文献求助收藏